LEI 549300FNJZS6NGFB6M31
Magle Chemoswed Holding AB
Group parent: Maria Magle Holding AB
Contract awards & public grants
Regenerative Medicine and Advanced Medicinal Therapeutic Products United for PhD excellence → MAGLE CHEMOSWED HOLDING AB
European Commission · SE · Grant · 2025-05-08
—
Hyper-targeting CAR NK cells from induced pluripotent stem cells for novel off-the-shelf anti-tumor therapies → MAGLE CHEMOSWED HOLDING AB
European Commission · SE · Grant · 2023-01-19
€219,237
Gene Therapy of Rare Diseases → MAGLE CHEMOSWED HOLDING AB
European Commission · SE · Grant · 2022-07-15
—
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.